In a highly dynamic market environment, pharmaceutical companies are grappling with challenges as they relate to evolving technology and cloud-based solutions in customer engagement, dealing with big data to customize customer experience and driving standardization, global compliance, and commercial effectiveness.
PHARMAFUTURE ™ 2016 will focus on the views of the captains of the industry about how external market dynamics are redefining the way companies organize themselves to remain competitive and drive commercial growth.
Panel Discussion I : External Transformation
Closing Remarks : Indegene17:30-17:45
Chief Strategy & Business Development Officer/ President - Emerging Businesses, Merck & Co., Inc.
Head, Multichannel Marketing Strategy & Operations, GlaxoSmithKline
Research Manager, Life Science Business System Strategies, International Data Corporation
Worldwide Multi-Channel Marketing Hub Head, Bristol-Myers Squibb
Corporate Senior Vice President – Head of Corporate Commercial Operations, Boehringer Ingelheim
VP & Franchise Head, US Oncology, Novartis
Director of Integrated Marketing, Specialty Brands, Mylan Pharmaceuticals
Executive Director Global Commercial Operations, AstraZeneca
Content Strategy Leader, Merck & Co., Inc.
PHARMAFUTURE ™ (www.pharmafuture.org) is a global thought leadership forum for senior pharmaceutical executives. Its objective is to bring together senior leaders of the industry in an interactive setting to discuss the key challenges the industry faces, share experiences, and brainstorm ideas and solutions to drive better health and business outcomes.
Over the last 3 years, PHARMAFUTURE ™ has become a highly regarded platform for an open and thought-provoking exchange of views among people who are entrusted with the key strategic decisions within the pharmaceutical industry.
PHARMAFUTURE ™ is an initiative of Indegene – a leading global health-care solutions company that integrates medical/pharmaceutical expertise, technology, analytics, and operational excellence to address some of the major challenges in the industry.